Botulinum toxin for the correction of hyperkinetic facial lines

Australasian Journal of Dermatology

Volumn 39, Issue 3, 1998, Pages 158-163

  Goodman, Greg ^a  

^a NONE   (Australia)

Author keywords

Botox ; Botulinum A exotoxin; Expression fines

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; EYEBROW; FACE MUSCLE; FEMALE; HUMAN; HYPERKINESIA; MALE; PTOSIS;

EID: 0031828945     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.1998.tb01272.x     Document Type: Article

References (41)

1. Scliiao G, Bcnfenati F, Poulain B et al. Tetanus and botulinum-B ncurotoxins block nenrolransmitlcr release by proleolylic cleavage of synaptobrevin. Xatiire 1992; 559: 832-5.
2. Jankovic J, Brin MF. Therapeutic uses ofbotulinuin toxin. A'. Engl. J.Mcd. 1991; 524: 1186-94.
3. Woodruff BA, Griffin PM, McCroskcy LM et al. Clinical and laboratory comparison of botulism from toxin types A, B and E in the United States, 1975-1988. J. Infect. Dis. 1992; 166: 1281-6.
4. Borodic GE, Pcarce LB, Smith KL, Phelan M, Ferrante R. Botulinum B toxin as an alternative to botulinum A toxin: A histologie study. Ophthal. Plast, lleconslr. Surg. 1993; 9: 182-90.
5. Wall SA, Chait LA, Temlelt JA. Botulinum A chcmodcnervation: A new modality in cerebral palsied hands. Br. J. 1'last. Surg. 1995; 43: 703-6.
6. Kristan RW, Satsior OG. Treatment of blepharospasm with high dose brow injection ofbotulinuin toxin. Oplitlial. Plast, fteconslr. Surg. 1987; 3: 25-7.
7. Biglan AW, May M, Bowers RA. Management of facial spasm witli clostridium botulinum toxin, type A (Oculinum). Arch. Otolar)-tigol. Head A'eck Surg. 1988; 114: 1407-12.
8. Borodic GE, Mills L, Joseph M. Botulinum A toxin for the treatment of adult-onset spasmodic torticollis. Plast. Rcconstr. Surg. 1991; 87: 285-9.
9. Jost WH, Schimrigk K. Botulinum toxin in therapy of anal fissure. Lancet 1995; 545: 188-9.
10. Pasricha PJ, Ravich WJ, Ilendrix TO, Sostrc S, Jones B, Kalloo B. Intrasphincteric botulinum toxin for the treatment of achalasia. A'. Engl. J. Mcd. 1995; 552: 774-8.
11. Shaari CM, Sanders I, Wu BL, Billcr HF. Rhinorrhca is decreased in dogs after nasal application of botulinum toxin. Ololaryngol. Head Neck Surg. 1995; 112:506-71.
12. Keen M, Blitzer A, Aviv J et al. Botulinum toxin A for hyperkinetic facial lines: Results of a double blind, placebo-controlled study. Plast. Reconstr. Surg. 1994; 94: 94-9.
13. Guyuron B, Huddleston SW. Aesthetic indications for botulinum toxin injection. Plast. Kcconslr. Surg. 1991; 95: 915-18.
14. Blitzer A, Brin MF, Keen MS, Aviv JE. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch. Ololatyngol. Head A'eck Surg. 1995; 119: 1018-22.
15. Carruthers JDA, Carruthers JA. Treatment of glabellar frown lines with C. Botulinum-A exotoxin./ Dennalol. Surg. Oncol. 1992; 18: 17-21.
16. Carruthers A, Carruthers JD. Botulinum toxin in the treatment of glabella frown lines and oilier facial wrinkles. In: Jakovic J, I lallet M (cds). Tlierapy with botulinum toxin. iS'ew York: Marcel Dekkcr, 1994; 577-95.
17. LowcNJ, Wieder JM. Botulinum toxin for hypcrkinelic facial lines. A placebo controlled study. Cosmet. Dennatol. 1995; 8: 46-7.
18. Scott AB, Suzuki D. Systemic toxicity of botulinum toxin by intramuscular injection in the monkey. Mov. Disord. 1988; 5: 333-5.
19. Carruthers A, Carrulhcrs J. Cosmetic users of botulinum toxin. In: Coleman WP III, Hanke CW, Alt Til, Askcn S (eds). Cosmetic Surgery of the Skin: Principles and Techniques, 2nd edn. St Louis: Mosby Year Book, Inc., 1997; 231-5.
20. on Garcia A, Fulton JE. Cosmetic denotation of the muscles of facial expression with botulinum toxin. A dose response study. Oennatol. Surg. 1996; 22: 39-43.
21. Gartlan MG, Hoffman HT. Crystalline preparation of botulinum toxin type A (Botox): Degradation in potency with storage. Otolaryngol. Head Neck Surg. 1993; 108: 135-40.
22. Klein AW. Cosmetic therapy with botulinum toxin. Anecdotal memoirs. Dennalol Surg. 1996; 9: 757-9.
23. Klein AW. Indications and implantation techniques for the various formulations of injectable collagen. J. Dermalol. Surg. Oncol. 1988; 14 (Suppl. 1): 27-30.
24. Cooperman LS, Mackinnon V, Bechler G, Pharris BB. Injectable collagen: A six-year clinical investigation. Aesthetic Plast. Surg. 1985; 9: 145-51. .
25. Hanke CW, Joliuette D, Stegman SJ et al. Abscess formation and local necrosis following treatment with Zyderm or Zyplast collagen implant. J. Am. Acad. Dermatol. 1991; 25: 319.
26. Cucin BL, Barek D. Complications of injectable collagen implant. Plast. Keconslr. Surg. 1983; 71: 731.
27. Driezen NG, Framin L. Sudden unilateral visual loss after autologous fat injection into the glabclla area. Am, J. Ophtlialmol. 1989; i07: 85-G.
28. Teimourian B. Blindness following fat injection. Plast. Reconstr. Surg. 1988; 92: 361.
29. Ersek RA. Transplantation of purified autologous fat: A 3-year follow up is disappointing. Plast. Reconstr. Surg. 1991; 87:219-27.
30. Shumrick KA, Kridel RWH. Comparison of injectable silicon vs collagen for soft tissue augmentation. J. Dcnnatol. Surg. Oncol. 1988; 14 (Suppl. 1): 66-72.
31. Maas CS, Gnepp DR, Bumpous J. Gore-Tex soft-tissue patch in facial augmentation, Arch. Otolarjwgol. HeadiVcckSiirg. 1993; 119: 1008-14.
32. Cisneros JL, Singla R. Inlradcrmal augmentation with expanded polytctrafluoroctliylcne (Gorc-Tex) for facial lines and wrinkles. J. Dermatol. Surg. Oncol. 1993; 19: 539-12.
33. Wolf DL. Complications following lip augmentation with GoreTex. Plast. Rcconstr. Surg. 1995; 95: 1334-5 (Letter).
34. Peer LA, Paddovk R. Histologie studies on the fate of deeply implanted dermal grafts: Observations on sections of implants buried from one week to one year. Arch. Surg. 1957; 34: 208.
35. Swinehart JM. Pocket grafting with dermal grafts: Autologous collagen implants for permanent correction of cutaneous depressions. Am. J. Cosmct. Surg. 1995; 12: 521-31.
36. Abergcl RP, Schlaak CM, Garcia LD et al. The laser dermal implant: A new technique for preparation and implantation of autologous dermal grafts for the correction of depressed scars, lip augmentation, and nasolabial folds using silk touch laser technology. Am. J. Cosmet. Surg. 1996; 15: 15-18.
37. Goodman GJ. Laser assisted dermal grafting for the correction of cutaneous contour defects. Demiatol. Surg. 1997; 25: 95-9.
38. Goodman GJ. Combining laser resurfacing and ancillary procedures. Dcrmalol. Surg. 1998; 24: 75-8.
39. Coleman WP III, Goodman GJ, Lawrence N. Combining skin resurfacing with soft tissue augmentation. In: Coleman WP III, Lawrence N (eds). Skin llesurfacing. Baltimore: Williams and Wilkins, 1998; 217-54.
40. Goodman GJ. The limitations of skin resurfacing techniques. The necessity to combine procedures. Dcrmatol. Surg. 1998 (in press).
41. Goodman GJ. Autologous fat and dermal grafting for the correction of facial scars. In: Ilarahap M (ed.). Treatment of scarring. Marcel Dekkcr 1998 (in press).